The following was published in IBD News Weekly. It is a

The following was published in IBD News Weekly. It is a subscription site if anyone is interested.

JANUARY 6, 2020
UK Regulatory Agency Approves Launch of Innovation’s Phase 1 Trial of Brilacidin for Ulcerative Colitis
NEWS
The United Kingdom’s Medicines and Healthcare products Regulatory Agency has approved the launch of Innovation Pharmaceuticals’ Phase 1 trial in healthy volunteers to investigate the safety and properties of ...